Home Other Building Blocks Acetic acid, calcium salt

Acetic acid, calcium salt

CAS No.:
62-54-4
Catalog Number:
AG01DO7X
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01DO7X
Chemical Name:
Acetic acid, calcium salt
CAS Number:
62-54-4
MDL Number:
MFCD00012448
IUPAC Name:
calcium;diacetate
InChI:
InChI=1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2
InChI Key:
VSGNNIFQASZAOI-UHFFFAOYSA-L
EC Number:
200-540-9
UNII:
Y882YXF34X
FEMA Number:
2228
RTECS Number:
AF7525000
Properties
Complexity:
25.5  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
157.989g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
158.166g/mol
Monoisotopic Mass:
157.989g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
80.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Sustained-release alginate-chitosan pellets prepared by melt pelletization technique. Drug development and industrial pharmacy 20121201
Shift in the equilibrium between on and off states of the allosteric switch in Ras-GppNHp affected by small molecules and bulk solvent composition. Biochemistry 20120807
Phosphate binders in CKD: bad news or good news? Journal of the American Society of Nephrology : JASN 20120801
Effects of phosphate binders in moderate CKD. Journal of the American Society of Nephrology : JASN 20120801
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. American journal of kidney diseases : the official journal of the National Kidney Foundation 20120201
Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis. American journal of kidney diseases : the official journal of the National Kidney Foundation 20120201
Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them? International urology and nephrology 20111201
Pharmacology, efficacy and safety of oral phosphate binders. Nature reviews. Nephrology 20110906
Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients. Clinical journal of the American Society of Nephrology : CJASN 20110901
Effects of six chemical deicers on larval wood frogs (Rana sylvatica). Environmental toxicology and chemistry 20110701
Spontaneous bilateral humeral shaft fracture due to severe renal osteodystrophia. The American journal of the medical sciences 20110701
Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique. Journal of pharmaceutical sciences 20110601
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20110501
Absorption of levothyroxine when coadministered with various calcium formulations. Thyroid : official journal of the American Thyroid Association 20110501
Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. American journal of kidney diseases : the official journal of the National Kidney Foundation 20110401
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. Nephron. Clinical practice 20110101
Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clinical journal of the American Society of Nephrology : CJASN 20110101
A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease. BMC nephrology 20110101
Fluorescence investigation of the retinal delivery of hydrophilic compounds via liposomal eyedrops. Biological & pharmaceutical bulletin 20110101
[Ultrastructural cellular alterations of the natronophilic endoevaporite cyanobacterium Euhalothece natronophila during fossilization]. Mikrobiologiia 20110101
Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4. International urology and nephrology 20101201
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20101101
A new process for producing calcium acetate from vegetable wastes for use as an environmentally friendly deicer. Bioresource technology 20101001
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients. Journal of the Formosan Medical Association = Taiwan yi zhi 20100901
Stomach calcification revealed by gastrofibroscopy in a haemodialysis patient. Nephrology (Carlton, Vic.) 20100801
Relative transcription of Listeria monocytogenes virulence genes in liver pâtés with varying NaCl content. International journal of food microbiology 20100731
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clinical journal of the American Society of Nephrology : CJASN 20100201
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood purification 20100101
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20100101
Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders? Journal of nephrology 20100101
[Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20100101
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data. Clinical journal of the American Society of Nephrology : CJASN 20091201
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20091001
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American journal of kidney diseases : the official journal of the National Kidney Foundation 20091001
Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients. Hemodialysis international. International Symposium on Home Hemodialysis 20090701
[Clinical aspect of recent progress in phosphate metabolism. Management of hyperphosphagtemia]. Clinical calcium 20090601
The use of phosphate binders: data from contributors to the European Practice Database. Journal of renal care 20090301
Oral phosphate binders for the management of serum phosphate levels in dialysis patients. Journal of renal care 20090301
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi. JPMA. The Journal of the Pakistan Medical Association 20090201
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090101
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. American journal of kidney diseases : the official journal of the National Kidney Foundation 20081201
In vivo response of bioactive PMMA-based bone cement modified with alkoxysilane and calcium acetate. Journal of biomaterials applications 20081101
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101
Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study. American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101
Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081001
[Pore structure and desulfurization characteristics of organic calcium]. Huan jing ke xue= Huanjing kexue 20080801
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. American journal of kidney diseases : the official journal of the National Kidney Foundation 20080601
Preparation, characterization, and evaluation of liposomal ferulic acid in vitro and in vivo. Drug development and industrial pharmacy 20080601
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney international 20080301
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice. American journal of kidney diseases : the official journal of the National Kidney Foundation 20080301
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data. American journal of kidney diseases : the official journal of the National Kidney Foundation 20080301
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clinical journal of the American Society of Nephrology : CJASN 20080101
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study. Academic radiology 20080101
Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study. Nephron. Clinical practice 20080101
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney international 20071101
Pursuing structure in microcrystalline solids with independent molecules in the unit cell using 1H-13C correlation data. Journal of magnetic resonance (San Diego, Calif. : 1997) 20071101
A spectroscopic study of the mineral paceite (calcium acetate). Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070701
Swelling, erosion and release behavior of alginate-based matrix tablets. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070601
Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir : the ACS journal of surfaces and colloids 20070327
Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement. International urology and nephrology 20070101
Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis. Journal of Ayub Medical College, Abbottabad : JAMC 20070101
Development of polysaccharide gel coated pellets for oral administration 1. Physico-mechanical properties. International journal of pharmaceutics 20061201
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20061101
Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060801
[Fluorine removal efficiency of organic-calcium during coal combustion]. Huan jing ke xue= Huanjing kexue 20060801
Mechanical and histological evaluation of a PMMA-based bone cement modified with gamma-methacryloxypropyltrimethoxysilane and calcium acetate. Biomaterials 20060701
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients. American journal of kidney diseases : the official journal of the National Kidney Foundation 20060601
Phosphate binders. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060415
A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation 20060401
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders. Nephrology (Carlton, Vic.) 20060401
The CARE study and cardiovascular calcification. Managed care (Langhorne, Pa.) 20060301
Controversies in the management of hyperphosphatemia in patients with end-stage renal disease. Managed care (Langhorne, Pa.) 20060301
Phosphate binders. The Medical letter on drugs and therapeutics 20060213
Preparation and characterization of anodized titanium surfaces and their effect on osteoblast responses. The Journal of oral implantology 20060101
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients. Renal failure 20060101
Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain. The Journal of pharmacology and experimental therapeutics 20051001
Interdialytic weight gain is less with the Mediterranean type of diet in hemodialysis patients. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20051001
Synthesis of bioactive PMMA bone cement via modification with methacryloxypropyltri-methoxysilane and calcium acetate. Journal of materials science. Materials in medicine 20050801
Conductance study of association in aqueous CaCl2, Ca(CH3COO)2, and Ca(CH3COO)2.nCH3COOH from 348 to 523 K at 10 MPa. The journal of physical chemistry. B 20050728
Consequences and management of hyperphosphatemia in patients with renal insufficiency. Kidney international. Supplement 20050601
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis. Kidney international. Supplement 20050601
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatric nephrology (Berlin, Germany) 20050501
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. American heart journal 20050501
Precipitation of hydroxyapatite nanoparticles: effects of precipitation method on electrophoretic deposition. Journal of materials science. Materials in medicine 20050401
Phosphorus management in end-stage renal disease. Seminars in dialysis 20050101
Calcium acetate-induced linear fixed drug eruption. Dermatology (Basel, Switzerland) 20050101
Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20050101
Phosphate intake and the CARE study. Kidney international 20041101
Application of central composite design and response surface methodology to the fermentation of olive juice by Lactobacillus plantarum and Debaryomyces hansenii. International journal of food microbiology 20040901
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study. Kidney international. Supplement 20040901
Calcium-enriched bread for treatment of uremic hyperphosphatemia. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20040701
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney international 20040501
Calcium bioavailability and kinetics of calcium ascorbate and calcium acetate in rats. Experimental biology and medicine (Maywood, N.J.) 20040101
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. The Journal of heart valve disease 20040101
[MIBI and parathyroid gland function in secondary hyperparathyroidism]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20040101
Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin. American journal of kidney diseases : the official journal of the National Kidney Foundation 20031201
Renal disease medications and evidence-biased medicine. Kidney international 20031001
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20031001
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients. Current opinion in nephrology and hypertension 20030701
Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate. Kidney international. Supplement 20030601
Phosphate binder usage in kidney failure patients. Expert opinion on pharmacotherapy 20030601
The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20030401
Calcium on trial: beyond a reasonable doubt? Kidney international 20030101
[Vascular and tissue calcifications of hemodialysis patients]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20030101
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. American journal of nephrology 20030101
Nutrient removal of ammonia rich effluents in a sequencing batch reactor. Water science and technology : a journal of the International Association on Water Pollution Research 20030101
Effect of phosphate binders on supplemental iron absorption in healthy subjects. Journal of clinical pharmacology 20021001
A preference study: calcium acetate tablets versus gelcaps in hemodialysis patients. Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20020801
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020701
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders. Cleveland Clinic journal of medicine 20020101
Metabolic and skeletal effects of low and high doses of calcium acetate in patients with preterminal chronic renal failure. American journal of nephrology 20020101
Crystallization of a complex between human CDK6 and a virus-encoded cyclin is critically dependent on the addition of small charged organic molecules. Acta crystallographica. Section D, Biological crystallography 20010901
Osteoporosis and mild metabolic acidosis in the rat after orchiectomy and their prevention: should prophylactic therapy be administered to patients with androgen deprivation? The Journal of urology 20010501
Impact of oral bases on aluminum absorption. American journal of therapeutics 20010101
Properties